skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

A unique perspective on the personal care industry

Rose_Sheet

How it helps

In the largely self-regulated personal care industry, it’s easy to forget how critical knowledge of class actions, legal risks, and product liability issues can be. Rose Sheet’s unique, objective viewpoint combines deep analysis of current market news with coverage of all the regulatory, legislative, legal, and business concerns that go along with it.  

How it works

Rose Sheet features in-depth coverage of topics including: 

  • Legislative developments in the US that tighten cosmetics regulations, plus developments in the EU and various emerging international markets
  • Ingredient safety, transparency and product liability issues  
  • “Natural” and ”organic” formulation, regulation, claims, and legal implications
  • Business development, marketing, and advertising strategies
  • New product launches, trademark reviews, cosmetic ingredients, science, and innovationDietary supplements, business developments, and safety issues

Protect your interests with exclusive information and analysis from Rose Sheet. 

 

What's included

ask the analyst pharma intelligence

Ask-the-Analyst™

 Unlimited support for your research from experienced industry analysts

Access to experts

Expert Analysis

Our analysts provide a high level of expertise and experience in all aspects of preclinical and clinical drug development

Hear from newsmakers

Hear from news makers

Access interviews with leading decision makers, industry experts and thought leaders, across the industry.

 

Meet the team

Analyst

Malcolm Spicer

Analyst, Lead analyst
Malcolm Spicer

Malcolm specializes in

  • Policy & Regulation

+15 year(s) experience

Management

Ryan Nelson

Management, Managing Editor of The Rose Sheet
Ryan Nelson

Ryan specializes in

  • Policy & Regulation

+11 year(s) experience

Reporter-Journalist

Eileen Francis

Reporter-Journalist, Reporter
Eileen Francis

Eileen specializes in

  • Policy & Regulation

+0 year(s) experience

How we've helped other businesses

"Scrip helps me to stay current with pharmaceutical news on a world-wide basis."

​Wendy Johnson ​CEO, Aires Pharmaceuticals, USA

"RxScorecard™ provides a comprehensive, multi-pronged rubric assisting us in decision-making as we begin to move from a volume to value drug evaluation methodology."

​Chronis H. Manolis, RPh ​Vice President, Pharmacy UPMC Health Plan

"RxScorecard™ lets a biopharma company anticipate the most important factors impacting the clinical & economic value of pipeline and marketed drugs -- and then helps identify the necessary changes to the clinical development and commercial program to maximize that value for all stakeholders, especially including payers. It's a required, straightforward, objective strategic tool that allows us to quickly and effectively adapt to a rapidly changing and much more challenging market access environment."

​Ammar Qadan ​Global Value/Market Access Lead Oncology Portfolio & Global Commercial Lead Oncology Biomarkers Halozyme Therapeutics, Inc.

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: